How do the urinary and erectile dysfunction side effects of atomoxetine (Strattera) compare to those of methylphenidate extended‑release (Concerta)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Strattera vs Concerta: Urinary and Erectile Dysfunction Side Effects

Strattera (atomoxetine) carries significantly higher risks of urinary and erectile dysfunction side effects compared to Concerta (methylphenidate), particularly in adult males, while Concerta shows minimal to no increased risk of these specific adverse effects.

Key Differences in Side Effect Profiles

Strattera (Atomoxetine) - Higher Genitourinary Risk

In adult males, atomoxetine demonstrates clinically significant genitourinary and sexual side effects 1, 2:

  • Erectile dysfunction: 8.0% (vs. 1.9% placebo)
  • Urinary hesitation: 6.9% (vs. 2.4% placebo)
  • Libido decreased: 4.6% (vs. 3.0% placebo)
  • Dysuria: 3.7% (vs. 1.5% placebo)
  • Ejaculation disorder: 2.8% (vs. 1.1% placebo)
  • Urine flow decreased: 2.5% (vs. 0.6% placebo)

The FDA label explicitly warns about "problems passing urine including trouble starting or keeping a urine stream" and "sexual side effects" as common adverse events in adults 1. Additionally, priapism, though rare, has been reported and requires immediate medical attention if erections persist beyond 4 hours 1, 3.

Time course matters: These side effects typically onset within the first 2 weeks for urinary symptoms and during weeks 2-3 for erectile/ejaculatory issues, with median resolution times ranging from 3-8 weeks after onset 2, 4.

Concerta (Methylphenidate) - Minimal Genitourinary Risk

The FDA label for Concerta does not list urinary dysfunction or erectile dysfunction as adverse effects 5. Recent systematic reviews indicate methylphenidate can have variable effects on sexual function—some patients report decreased libido while others experience enhanced arousal—but these effects are highly individual and not consistently documented as adverse events in clinical trials 6.

Gender and Age Considerations

Critical distinction: The sexual and genitourinary side effect profiles differ dramatically by population:

  • Adult males: Atomoxetine shows substantially elevated risk; methylphenidate shows minimal documented risk
  • Adult females: Both medications show similar, low rates of sexual/urinary side effects 2
  • Adolescent males: Both medications show comparable, low rates of these side effects 2

Clinical Decision Algorithm

For adult males concerned about urinary or erectile function:

  1. First-line: Choose Concerta (methylphenidate) - minimal documented genitourinary risk
  2. If methylphenidate fails or is contraindicated, consider atomoxetine with explicit counseling about the 8% erectile dysfunction risk and 6.9% urinary hesitation risk
  3. Monitor closely during weeks 1-3 of atomoxetine treatment when these side effects most commonly emerge

For adult females or adolescents:

  • Both medications show similar, low genitourinary side effect profiles
  • Base choice on other clinical factors (efficacy, comorbidities, abuse potential concerns)

Important Caveats

While atomoxetine carries FDA warnings about urinary retention and priapism 1, most sexual and genitourinary adverse events are not severe and many resolve within 3-8 weeks 2. However, discontinuation rates due to adverse events are significantly higher with atomoxetine (17.2%) versus placebo (5.6%) 7, suggesting these side effects meaningfully impact tolerability.

The evidence base shows atomoxetine's genitourinary effects are likely underreported in clinical trials 2, meaning real-world rates may be even higher than documented percentages.

Bottom line for prescribing: If urinary function or erectile function is a priority concern in an adult male patient, methylphenidate (Concerta) is the clear choice based on its minimal documented risk profile for these specific adverse effects 8, 6.

References

Related Questions

Can dexamphetamine cause increased libido and compulsive sexual behaviors such as excessive masturbation and pornography use, and should I discontinue the medication?
Does ADHD medication such as Adderall (mixed amphetamine salts) cause erectile dysfunction in a 37‑year‑old male, and how should it be managed?
Can Strattera (atomoxetine) cause decreased urination?
Does Concerta (methylphenidate) cause sexual dysfunction (e.g., decreased libido, erectile difficulty, delayed orgasm), and how should it be managed?
Do stimulant medications increase the risk of erectile dysfunction in adult males?
Does a right knee sprain after anterior cruciate ligament (ACL) reconstruction, combined with left knee sprain, left knee instability, and surgical scars on both knees, cause obesity?
Which laboratory test can confirm that a serum vitamin B12 level is not falsely elevated?
In adults with acute COPD exacerbation—especially elderly patients with low serum magnesium, severe dyspnea, wheezing, or hypercapnic respiratory failure—does early intravenous magnesium sulfate administration reduce the likelihood of hospital admission from the emergency department?
What pain injection options are available that do not contain steroids?
What is the Mediterranean diet?
How many hours of sleep does an 8-year-old child need per night?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.